Mylan Nabs Partial Win On EpiPen Claims, Still Faces Trial
Mylan will not face racketeering claims or claims over its rebates for the EpiPen in a scheduled September trial in Kansas federal court, but a jury will still hear allegations from...To view the full article, register now.
Already a subscriber? Click here to view full article